Fresh analysis indicates that people who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt traditional diet and exercise regimens.
Research printed in a leading health publication points out that while obese people often shed substantial amounts of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.
"People purchasing these drugs must be aware of the danger of quick rebound weight gain when the therapy ends," cautioned researcher Dr. Susan Jebb.
This pace of recovery suggests a return to original weight within about 18 months.
Analyzing Therapies
The study, which examined dozens of trials involving over 9,000 of participants, compared the results of the injectable medications with other pills.
Researchers emphasize that people who lose weight through dieting usually have a less rapid weight regain—approximately 100 grams monthly—once they finish.
Understanding the Rapid Regain
Nutrition scientists believe the way of the jabs is key to understanding the accelerated regain.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating a significant risk."
A Lifelong Disease?
Health authorities suggest the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts say that, given the likelihood of weight regain, the therapy should be considered life-long.
This opinion is supported by pharmaceutical companies, who state that the results "underscore the long-term nature of excess weight," similar to managing diseases like hypertension.
User Testimonies
Individuals who have discontinued the medication explain a intense return of cravings.
"It was like a switch activating and you're instantly ravenous," described one woman.
This difficulty is exacerbated if users have not established sustainable lifestyle or habit changes during treatment.
Significant Adoption
Figures show that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is more common among women than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Finally, clinicians caution that while the jabs are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on combined lifestyle management.
